This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2025. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 10 | 750,000 | 1,080,262 | 95,257 | 95,257 | 100,000 | 100,000 | 100,000 | 750,000 | 757,376 | 1,511,333 | 2,132,238 | 2,518,838 | 2,737,574 |
| Global health | 10 | 750,000 | 1,080,262 | 95,257 | 95,257 | 100,000 | 100,000 | 100,000 | 750,000 | 757,376 | 1,511,333 | 2,132,238 | 2,518,838 | 2,737,574 |
| Donor | Total | 2017 | 2016 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 10,802,616.00 | 1,511,333.00 | 4,869,812.00 | 852,633.00 | 2,518,838.00 | 850,000.00 | 100,000.00 | 100,000.00 |
| Total | 10,802,616.00 | 1,511,333.00 | 4,869,812.00 | 852,633.00 | 2,518,838.00 | 850,000.00 | 100,000.00 | 100,000.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 10) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 1,511,333.00 | 4 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to characterize the penetration and distribution of new TB drug candidates in the lung to guide the selection of optimal regimens for the treatment of TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,132,238.00 | 3 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to test the efficacy of host directed therapy on sterilizing Mtb (Mycobacterium TB) during latent infection and preventing reactivation; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,737,574.00 | 1 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to enable the discovery and development of more effective, faster acting drug regimens for drug sensitive and drug resistant TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 757,376.00 | 5 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to validate a rabbit model that mimics the range of human manifestations of pulmonary TB as a platform for evaluating candidate TB vaccines for the ability to induce sterilizing immunity and/or protect against progression to cavitary TB following challeng; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 95,257.00 | 10 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a simple methodology that extracts Mycobacterium tuberculosis from sputum samples, enabling future rapid point-of-care tests for tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,518,838.00 | 2 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to enable the discovery of effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease, by integrating plasma and lesion pharmacokinetic profiling of existing drugs, hits, leads, and clinical development candidates.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 750,000.00 | 6 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a simple methodology that extracts Mycobacterium tuberculosis from sputum samples, enabling future rapid point-of-care tests for tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 7 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to engineer strains of bacteria found in the human gut to produce the vitamin A precursor beta-carotene, and test the hypothesis that vitamin A-deficiency could be controlled and promote healthy growth of children; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 7 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to evaluate the effectiveness of the natural antimicrobial protein subtilosin to not only treat vaginal infections but also act as a spermicidal agent; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 7 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to develop transgenic tomatoes that express RNAs that targets several relevant viruses. The team will test whether these antiviral RNAs can accumulate in mammals after their ingestion to suppress viral proliferation.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |